Psychedelic Stocks UK-Based Small Pharma Secures Regulatory Green Light To Investigate DMT’s Potential Therapeutic Properties By Larry Zweig January 05, 2021 Psychedelics such as dimethyltriptamine (DMT) have been gaining popularity not only due to the euphoria they provide but also because they are claimed to have therapeutic properties. UK regulators have weighed in on those claims a...
Psychedelic Stocks UK Regulators Approve Clinical Trial Testing DMT as a Potential Depression Treatment By Larry Zweig December 22, 2020 UK watchdogs recently gave the green light to researchers exploring the potential medical properties of psychedelics. The approval will allow researchers to study dimethyltryptamine (DMT) as a potential treatment for depression. ...
Psychedelic Stocks UK Regulators Explore DMT As A Potential Anti-Depression Therapy By Larry Zweig December 19, 2020 UK researchers are planning to conduct a clinical study that will give them insights into dimethyltryptamine’s (DMT) mechanisms that provide therapeutic advantages against mental health illnesses. The research will be backed by...
